
Timothy Ko, CEO of Entheon Biomedical
by Nick Opich on December 10, 2020 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
by Nick Opich on December 10, 2020 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Timothy Ko, CEO of Entheon Biomedical, a company that is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule, is this week’s special guest on The Green Rush!
Entheon exists to invert the addiction-recovery ratio, turning the ‘untreatable case’ and ‘lost cause’ from the norm to the exception. When it comes to treating addiction, the rate of success is so low that society has been conditioned to accept – and even expect – failure. This manner of thinking is both unacceptable and counterproductive. There is a need for an alternative approach, that addresses the human cost of addiction for individuals, families and society at large. Entheon is developing a DMT-assisted therapeutic protocol that will be specifically tailored to address the core mechanisms underlying drug-seeking and using behavior.
For hosts Nick and Phil Carlson, this is one of the most powerful interviews we have ever had on The Green Rush. It was great getting to chat with Tim and his story is one we think our audience will truly enjoy.
So don’t sit back, lean forward and enjoy!
Timothy Ko, Chief Executive Officer at Entheon Biomedical
Timothy Ko has a broad background of leading private ventures in the Service Sector, Investor Relations, Retail and Technology. Timothy’s passion for the psychedelic space is shaped by firsthand knowledge of the shortcomings of the current mental health system, and through his exposure to psychedelics which he credits with saving his life.
Links and mentions in the show
Links to the guest’s company and social media accounts
Show Credits:
This episode was hosted by Nick Opich and Phil Carlson of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
Twitter: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/
Facebook: https://www.facebook.com/TheGreenRushPodcast/
YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Anne Donohoe are back for a new episode with special guest Sue Taylor, Co-Founder and Executive Director of The Farmacy, a family of retail stores in […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich are back for a new episode with special guest Charles Lazarus, Chief Cultivation & Production Officer at Rose Hill. Charles joins us this week […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Anne Donohoe are back for a new episode with special guest Kris Krane, Director of Cannabis Development for KCSA Strategic Communications. Kris joins us this week […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe is back, alongside first time-host – longtime producer (sorta!) and fellow KCSAer Emmaline Lewis, for a new episode with special guests Jim Fadiman, PhD, Independent Microdosing Researcher […]